CorVel Corporation
CRVL
Rangering i aksjer
#4002
CorVel Corporation delivers comprehensive solutions designed to assist... CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.
Aksjekurs
$81.14
Sist synkronisert: 2026-10-20
Markedsverdi
$4.10B
Endring (1 dag)
1.79%
Endring (1 år)
6.25%
Land
US
Handel CorVel Corporation (CRVL)
Kategori
Financial Services
P/E-forhold for CorVel Corporation (CRVL)
P/E-forhold per October 2026 TTM: 35.73
Ifølge CorVel Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 35.73. Ved slutten av 2024 hadde selskapet en P/E på 57.65.
P/E-forholdshistorikk for CorVel Corporation fra 2000 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 35.73 | -40.90% |
| 2025 | 60.46 | 4.88% |
| 2024 | 57.65 | 16.03% |
| 2023 | 49.69 | 10.34% |
| 2022 | 45.03 | 13.47% |
| 2021 | 39.68 | 88.21% |
| 2020 | 21.09 | -20.18% |
| 2019 | 26.41 | -0.92% |
| 2018 | 26.66 | -6.96% |
| 2017 | 28.65 | 3.21% |
| 2016 | 27.76 | 14.82% |
| 2015 | 24.18 | -20.83% |
| 2014 | 30.54 | 35.33% |
| 2013 | 22.57 | 22.79% |
| 2012 | 18.38 | -30.28% |
| 2011 | 26.36 | 57.30% |
| 2010 | 16.76 | 30.64% |
| 2009 | 12.83 | -29.24% |
| 2008 | 18.13 | -20.84% |
| 2007 | 22.90 | 4.56% |
| 2006 | 21.91 | 0.11% |
| 2005 | 21.88 | -8.49% |
| 2004 | 23.91 | 14.05% |
| 2003 | 20.96 | -6.96% |
| 2002 | 22.53 | 10.84% |
| 2001 | 20.33 | 16.40% |
| 2000 | 17.46 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 22.25 | -37.72% |
US
|
|
| 38.86 | 8.75% |
US
|
|
| 15.10 | -57.75% |
IE
|
|
| - | - |
GB
|
|
| - | - |
US
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.